|
I agree, as people who benefit from being in technologically more accessible countries we really do need to keep a sharp focus on what will be most meaningful for people in other circumstances.
As a chemophobic patient, I must admit that perhaps getting blasted with Adriamycin might possibly have been helpful to me -- although having been left out of consideration entirely in the traztuzumab clinical trials, I don't have much faith in the basis for the treatment I received as a HER2+++.
A.A.
|